Current Studies and Future Directions of Exercise Therapy for Muscle Atrophy Induced by Heart Failure

被引:6
|
作者
Liu, Qi [1 ]
Gao, Juan [2 ]
Deng, Jiali [1 ]
Xiao, Junjie [1 ,2 ]
机构
[1] Shanghai Univ, Inst Cardiovasc Sci, Cardiac Regenerat & Ageing Lab, Sch Life Sci, Shanghai, Peoples R China
[2] Shanghai Univ, Sch Med, Shanghai, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
exercise; muscle; atrophy; therapy; targets; SKELETAL-MUSCLE; RESISTANCE EXERCISE; SATELLITE CELLS; AUTOPHAGY; FITNESS; INTERVENTION; MITOCHONDRIA; INFLAMMATION; ACTIVATION; CAPACITY;
D O I
10.3389/fcvm.2020.593429
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Muscle atrophy is a common complication of heart failure. At present, there is no specific treatment to reverse the course of muscle atrophy. Exercise training, due to the safety and easy operation, is a recommended therapy for muscle atrophy induced by heart failure. However, the patients with muscle atrophy are weak in mobility and may not be able to train for a long time. Therefore, it is necessary to explore novel targets of exercise protection for muscle atrophy, so as to improve the quality of life and survival rate of patients with muscular atrophy induced by heart failure. This article aims to review latest studies, summarize the evidence and limitations, and provide a glimpse into the future of exercise for the treatment of muscle atrophy induced by heart failure. We wish to highlight some important findings about the essential roles of exercise sensors in muscle atrophy induced by heart failure, which might be helpful for searching potential therapeutic targets for muscle wasting induced by heart failure.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Atrial Fibrillation in Patients with Heart Failure: Current State and Future Directions
    Mene-Afejuku, Tuoyo O.
    Lopez, Persio D.
    Akinlonu, Adedoyin
    Dumancas, Carissa
    Visco, Ferdinand
    Mushiyev, Savi
    Pekler, Gerald
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2018, 18 (05) : 347 - 360
  • [22] Settling the IRONy of Anemia in Heart Failure: Current Evidence and Future Directions
    Tsangaris, Adamantios
    Ambrosy, Andrew P.
    Tschida, Michael
    Alexy, Tamas
    JOURNAL OF CARDIAC FAILURE, 2024, 30 (05) : 691 - 693
  • [23] Response to Letter Regarding Article, "Cell Therapy for Heart Failure: A Comprehensive Overview of Experimental and Clinical Studies, Current Challenges, and Future Directions"
    Bolli, Roberto
    Birks, Emma
    Flaherty, Michael P.
    Keith, Matthew
    Ghafghazi, Shahab
    CIRCULATION RESEARCH, 2014, 115 (11) : E33 - E34
  • [24] Skeletal muscle atrophy,regeneration,and dysfunction in heart failure:Impact of exercise training
    Harrison Gallagher
    Paul W.Hendrickse
    Marcelo G.Pereira
    T.Scott Bowen
    Journal of Sport and Health Science, 2023, 12 (05) : 557 - 567
  • [25] Skeletal muscle atrophy, regeneration, and dysfunction in heart failure: Impact of exercise training
    Gallagher, Harrison
    Hendrickse, Paul W.
    Pereira, Marcelo G.
    Bowen, T. Scott
    JOURNAL OF SPORT AND HEALTH SCIENCE, 2023, 12 (05) : 557 - 567
  • [26] Enhanced expression of EcSOD in skeletal muscle blocks chronic heart failure-induced muscle atrophy and exercise intolerance in mice
    Okutsu, Mitsuharu
    Lira, Vitor A.
    Zhang, Mei
    Yan, Zhen
    FASEB JOURNAL, 2012, 26
  • [27] Heart failure registries - Future directions
    Pol, Tymon
    Karlstrom, Patric
    Lund, Lars H.
    JOURNAL OF CARDIOLOGY, 2024, 83 (02) : 84 - 90
  • [28] Diuretic Treatment in Patients with Heart Failure: Current Evidence and Future Directions-Part II: Combination Therapy
    Cuthbert, J. J.
    Cleland, J. G. F.
    Clark, A. L.
    CURRENT HEART FAILURE REPORTS, 2024, 21 (02) : 115 - 130
  • [29] Using Biomarkers to "Guide" Heart Failure Management: Current Perspectives and Future Directions
    Motiwala, Shweta R.
    Januzzi, James L., Jr.
    CARDIOLOGY IN REVIEW, 2013, 21 (03) : 127 - 134
  • [30] Management of Heart Failure with Preserved Ejection Fraction: Current Challenges and Future Directions
    Bharathi Upadhya
    Dalane W. Kitzman
    American Journal of Cardiovascular Drugs, 2017, 17 : 283 - 298